0000014272-14-000002.txt : 20140102 0000014272-14-000002.hdr.sgml : 20140101 20140102160641 ACCESSION NUMBER: 0000014272-14-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140101 FILED AS OF DATE: 20140102 DATE AS OF CHANGE: 20140102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas J. Jr. CENTRAL INDEX KEY: 0001474056 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 14501867 MAIL ADDRESS: STREET 1: 800 HOWARD AVENUE STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06519 3 1 wf-form3_138869678967110.xml FORM 3 X0206 3 2014-01-01 1 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001474056 Lynch Thomas J. Jr. BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 0 0 0 Exhibit 24 - Thomas J. Lynch, Jr., M.D. /s/ Katherine R. Kelly, attorney-in-fact for Thomas J. Lynch, Jr. M.D. 2014-01-02 EX-24 2 poa.txt EXHIBIT 24 - THOMAS J. LYNCH, JR., M.D. Exhibit 24 POWER OF ATTORNEY I, Thomas J. Lynch, Jr., M.D., Director of Bristol-Myers Squibb Company (the "Company"), a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung, Katherine R. Kelly, and Robert J. Wollin, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, with respect to securities issued by the Company, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions. This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4, and 5 with respect to securities issued by the Company, unless earlier revoked. IN WITNESS WHEREOF, I have executed this Power of Attorney on this 18th day of December, 2013. /s/ Thomas J. Lynch, Jr., M.D. Thomas J. Lynch, Jr., M.D.